Physician profile
Parrish Moree
NPI 1518123447
$2,549.81
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,686 · 2020: $175 · 2021: $242 · 2022: $377 · 2023: $37.48 · 2024: $31.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $69.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $69.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,471.20 | 2019 | |
| Astellas Pharma US INC | $293.82 | 2019-2021 | |
| Rochester Medical Corporation | $131.38 | 2022 | |
| Boston Scientific Corporation | $103.23 | 2019-2024 | Rezum Generator |
| Axonics, INC. | $100.89 | 2020-2024 | Axonics |
| Conmed Corporation | $61.01 | 2022 | |
| Pfizer INC. | $53.72 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $46.48 | 2022 | |
| Olympus America INC. | $38.69 | 2019-2020 | |
| C. R. Bard, INC. & Subsidiaries | $37.48 | 2023 | Bard Urinary Drainage Bag |
| Allergan, INC. | $34.41 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.80 | 2022 | |
| Antares Pharma, INC. | $28.55 | 2019-2021 | |
| Teleflex LLC | $28.27 | 2021 | |
| Urovant Sciences INC | $22.99 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $21.64 | 2022 | |
| Myovant Sciences INC. | $15.87 | 2022 | |
| Amgen INC. | $15.62 | 2022 | |
| Endo Pharmaceuticals INC. | $11.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parrish Moree listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.